Results 241 to 250 of about 466,481 (267)

Posttreatment Amyloid Levels and Clinical Outcomes Following Donanemab for Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ 2 Randomized Clinical Trial.

open access: yesJAMA Neurol
Lu M   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy